Medically reviewed by Anju Goel, MD Allergies commonly cause itchy eyes, sneezing, and a stuffy nose. Allergies can also ...

adjunctive treatment, supportive care, and management of long-term effects. Given the similarities in clinical presentation, diagnosis, and management approaches across different forms of acute ...

The aim of this updated evidence-based clinical guideline is to facilitate uniformity of diagnosis and treatment of acute LAS injury, with the primary purpose of reducing the long-term ...

adjunctive treatment, supportive care, and management of long-term effects. Given the similarities in clinical presentation, diagnosis and management approaches across different forms of acute ...

The updated draft pneumonia: diagnosis and management clinical guideline opens for public consultation ... including urinary tract infections and acute bronchitis Community-acquired pneumonia (CAP) ...

Acute bronchitis typically resolves on its own with rest and home remedies within 2 to 3 weeks. Healthline has strict sourcing guidelines and relies on peer-reviewed studies, academic research ...

Methods A retrospective analysis of acute ischemic stroke cases associated with non-occlusive intraluminal thrombus of intracranial and extracranial arteries in the corresponding vascular territories ...

Treatment for allergic bronchitis begins with removing the exposure to the allergen causing the problem. If your condition is caused by seasonal allergens, your healthcare provider may recommend ...

ACP recommends adding triptan to NSAID or acetaminophen to treat moderate-to-severe acute episodic migraine. HealthDay News — In a clinical guideline ... the pharmacologic treatment of acute ...

Domain 1: Contemporary Views on Acute Bronchitis Guidelines and Antibiotic Prescribing ... might believe antibiotics are the correct treatment: "I expect there might be some physicians who ...

Per the study protocol, patients received itolizumab within 3-days of the first administration of high-dose corticosteroids with a treatment period from Days 1-99, and a follow-up period from Days ...

Itolizumab's potential as a first-line treatment for acute GVHD is highlighted by reduced mortality and improved outcomes. Although itolizumab did not improve response rates at Day 29 for patients ...